MIYABASHIRA ASUKA enters TAKEDA PHARMACEUTICAL CO LTD with 3K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001395064-26-000086
Officer· President, Japan Pharma B.U.
Since Mar 2026
3K
Baseline shares
100% direct
3K
Direct ownership
1 position
2.26K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned3K
Total
3K direct3K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 3K | Direct |
| Total | 3K | 3K direct |
Derivative Holdings3
Tax Obligation Award
DirectUnderlying security
Ordinary Shares
Underlying shares
728.00
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Tax Obligation Award
DirectUnderlying security
Ordinary Shares
Underlying shares
510.00
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Tax Obligation Award
DirectUnderlying security
Ordinary Shares
Underlying shares
1.02K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
2.26K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Tax Obligation Award Direct | Ordinary Shares | — | — | 728.00 | N/A | |
| Tax Obligation Award Direct | Ordinary Shares | — | — | 510.00 | N/A | |
| Tax Obligation Award Direct | Ordinary Shares | — | — | 1.02K | N/A | |
| Total | 2.26K | 0.00 | ||||